819 Capital Partners acquires CamperDays

Deventer, 23 October 2026 – 819 Capital Partners announces the acquisition of CamperDays through 819 Private Equity Fund I. Headquartered in Cologne, Germany, CamperDays is a leading international platform for campervan and motorhome rentals. The acquisition of CamperDays further strengthens 819 Capital Partners’ portfolio in the travel and leisure sector.

Continue reading “819 Capital Partners acquires CamperDays”

Phosphoenix Secures €1.3 Million to Advance Visual Neuroprosthetic Technology

16 September 2026, Deventer, the Netherlands – Phosphoenix, a medical technology company developing a neuroprosthetic system for people with profound blindness, has completed a €1.3 million financing round from TTT MedTech Fund (managed by 819 Capital Partners), FIRST Fund (managed by BioGeneration Ventures), Innovatiefonds Noord-Holland and ROM InWest as new investor.

Continue reading “Phosphoenix Secures €1.3 Million to Advance Visual Neuroprosthetic Technology”

819 Capital Partners invests in TracXon

Deventer, 1 September 2026 – 819 Capital Partners today announced a €1 million investment in TracXon, a deep-tech spin-off from TNO. The capital injection will accelerate the commercialization of TracXon’s breakthrough Flexible Hybrid Electronics (FHE) manufacturing platform, extending the company’s September 2025 financing round of €4.75 million led by DeepTechXL, with participation of Invest-NL and the Brabant Development Agency (BOM).

Continue reading “819 Capital Partners invests in TracXon”

819 Capital Partners invests in 20face

Deventer, 17 August 2026 – 20face, a Dutch start-up and spin-off of the University of Twente, is accelerating the commercialization of its facial recognition platform with a new investment from 819 Capital Partners. The investment, made through 819 Evergreen Fund, alongside existing investors, allows 20face to further build out its go-to-market capabilities and take its technology into new markets and sectors.

Continue reading “819 Capital Partners invests in 20face”

819 Capital Partners invests in Wolk

Deventer, 9 April 2026 – Dutch company Wolk has raised €1.75 million to accelerate the deployment of its smart hip airbag in elderly care. The investment round was led by 819 Capital Partners, through 819 Seed Fund I, and the Innovatiefonds Ouderenzorg of CbusineZ (CZ), with participation from Nivogé, Catalyst Impact Investment Club, and several angel investors.

Continue reading “819 Capital Partners invests in Wolk”

819 Capital Partners acquires key assets of Lead Pharma, enabling continuation of operations

Deventer, 6 March 2026 – 819 Capital Partners has acquired the key assets of Lead Pharma, thereby realizing a continuation based on the company’s patent portfolio and associated research programs.

The transaction includes intellectual property rights, research data, and selected development programs.

Continue reading “819 Capital Partners acquires key assets of Lead Pharma, enabling continuation of operations”